RNA Based COVID-19 Vaccine Candidates in Clinical Phase
The number of cases and disease-dependent deaths continue to increase worldwide due to the COVID-19 infection accepted as a global pandemic by the World Health Organization on March 11, 2020. Therefore, the antivirals used in treatment and vaccines that are the most effective weapons for protection...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bilimsel Tip Yayinevi
2021-06-01
|
| Series: | Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |
| Subjects: | |
| Online Access: | http://floradergisi.org/managete/fu_folder/2021-02/227-231%20Leyla%20ipek%20Rudvan%20Al.pdf |
| _version_ | 1797915678689198080 |
|---|---|
| author | Leyla İpek Rudvan Al Meliha Çağla Sönmezer Serhat Ünal |
| author_facet | Leyla İpek Rudvan Al Meliha Çağla Sönmezer Serhat Ünal |
| author_sort | Leyla İpek Rudvan Al |
| collection | DOAJ |
| description | The number of cases and disease-dependent deaths continue to increase worldwide due to the COVID-19 infection accepted as a global pandemic by the World Health Organization on March 11, 2020. Therefore, the antivirals used in treatment and vaccines that are the most effective weapons for protection remain the most popular topic on the agenda. There are a few conditions that might have an impact on the course of the pandemic, including the mutation of the virus and losing its ability to cause disease, generating herd immunity by reaching a critical rate of immunized people in the community due to the disease, and ensuring herd immunity through effective vaccination. Vaccine trials, which have started owing to the severity and urgency of the situation we are in, continue highly rapidly and effectively. According to the March 2, 2021 data of WHO, there are 258 vaccine trials, 76 of which are at the clinical phase, and 9 of the vaccine trials that are at the clinical phase are RNA-based vaccines. In our study, it was aimed to investigate RNA-based COVID-19 vaccine candidates and review their current data. |
| first_indexed | 2024-04-10T12:46:24Z |
| format | Article |
| id | doaj.art-939cb4bd83d34f11a227fda2ac744fae |
| institution | Directory Open Access Journal |
| issn | 1300-932X 1300-932X |
| language | English |
| last_indexed | 2024-04-10T12:46:24Z |
| publishDate | 2021-06-01 |
| publisher | Bilimsel Tip Yayinevi |
| record_format | Article |
| series | Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |
| spelling | doaj.art-939cb4bd83d34f11a227fda2ac744fae2023-02-15T16:14:04ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X1300-932X2021-06-0126222723110.5578/flora.20219802RNA Based COVID-19 Vaccine Candidates in Clinical PhaseLeyla İpek Rudvan Al0https://orcid.org/0000-0002-7261-6512Meliha Çağla Sönmezer1https://orcid.org/0000-0001-6657-1779Serhat Ünal2https://orcid.org/0000-0003-1184-4711Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, TurkeyThe number of cases and disease-dependent deaths continue to increase worldwide due to the COVID-19 infection accepted as a global pandemic by the World Health Organization on March 11, 2020. Therefore, the antivirals used in treatment and vaccines that are the most effective weapons for protection remain the most popular topic on the agenda. There are a few conditions that might have an impact on the course of the pandemic, including the mutation of the virus and losing its ability to cause disease, generating herd immunity by reaching a critical rate of immunized people in the community due to the disease, and ensuring herd immunity through effective vaccination. Vaccine trials, which have started owing to the severity and urgency of the situation we are in, continue highly rapidly and effectively. According to the March 2, 2021 data of WHO, there are 258 vaccine trials, 76 of which are at the clinical phase, and 9 of the vaccine trials that are at the clinical phase are RNA-based vaccines. In our study, it was aimed to investigate RNA-based COVID-19 vaccine candidates and review their current data.http://floradergisi.org/managete/fu_folder/2021-02/227-231%20Leyla%20ipek%20Rudvan%20Al.pdfrna based vaccinescovid-19 |
| spellingShingle | Leyla İpek Rudvan Al Meliha Çağla Sönmezer Serhat Ünal RNA Based COVID-19 Vaccine Candidates in Clinical Phase Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi rna based vaccines covid-19 |
| title | RNA Based COVID-19 Vaccine Candidates in Clinical Phase |
| title_full | RNA Based COVID-19 Vaccine Candidates in Clinical Phase |
| title_fullStr | RNA Based COVID-19 Vaccine Candidates in Clinical Phase |
| title_full_unstemmed | RNA Based COVID-19 Vaccine Candidates in Clinical Phase |
| title_short | RNA Based COVID-19 Vaccine Candidates in Clinical Phase |
| title_sort | rna based covid 19 vaccine candidates in clinical phase |
| topic | rna based vaccines covid-19 |
| url | http://floradergisi.org/managete/fu_folder/2021-02/227-231%20Leyla%20ipek%20Rudvan%20Al.pdf |
| work_keys_str_mv | AT leylaipekrudvanal rnabasedcovid19vaccinecandidatesinclinicalphase AT melihacaglasonmezer rnabasedcovid19vaccinecandidatesinclinicalphase AT serhatunal rnabasedcovid19vaccinecandidatesinclinicalphase |